Một đánh giá về bằng chứng cho con đường Wnt kinh điển trong rối loạn phổ tự kỷ

Beglinger LJ, Smith TH: A review of subtyping in autism and proposed dimensional classification model. J Autism Dev Disord. 2001, 31: 411-422. 10.1023/A:1010616719877. Volkmar FR, State M, Klin A: Autism and autism spectrum disorders: diagnostic issues for the coming decade. J Child Psychol Psychiatry. 2009, 50: 108-115. 10.1111/j.1469-7610.2008.02010.x. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff A, Yuzda E, Rutter M: Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995, 25: 63-77. 10.1017/S0033291700028099. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA: Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009, 163: 907-914. 10.1001/archpediatrics.2009.98. Gillis RF, Rouleau GA: The ongoing dissection of the genetic architecture of autistic spectrum disorder. Mol Autism. 2011, 2: 12-10.1186/2040-2392-2-12. Polleux F, Lauder JM: Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev. 2004, 10: 303-317. 10.1002/mrdd.20044. Freitag CM: The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007, 12: 2-22. 10.1038/sj.mp.4001896. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T: Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 2010, 26: 363-372. 10.1016/j.tig.2010.05.007. Anney RJ, Kenny EM, O’Dushlaine C, Yaspan BL, Parkhomenka E, Buxbaum JD, Sutcliffe J, Gill M, Gallagher L, Autism Genome Project: Gene-ontology enrichment in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders. Eur J Hum Genet. 2011, 19: 1082-1089. 10.1038/ejhg.2011.75. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D: Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron. 2011, 70: 898-907. 10.1016/j.neuron.2011.05.021. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, Zoghbi HY: Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med. 2011, 3: 86ra49-10.1126/scitranslmed.3002166. Hussman JP, Chung RH, Griswold AJ, Jaworski JM, Salyakina D, Ma D, Konidari I, Whitehead PL, Vance JM, Martin ER, Cuccaro ML, Gilbert JR, Haines JL, Pericak-Vance MA: A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism. 2011, 2: 1-10.1186/2040-2392-2-1. Nelson WJ, Nusse R: Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004, 303: 1483-1487. 10.1126/science.1094291. Gao C, Chen YG: Dishevelled: the hub of Wnt signaling. Cell Signal. 2010, 22: 717-727. 10.1016/j.cellsig.2009.11.021. Buechling T, Boutros M: Wnt signaling: signaling at and above the receptor level. Curr Top Dev Biol. 2011, 97: 21-53. Kikuchi A, Yamamoto H, Sato A, Matsumoto S: New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol. 2011, 291: 21-71. Hay E, Fauchau C, Suc-Royer I, Touitou R, Stiot V, Vayssiere B, Baron R, Roman-Roman S, Rawadi G: Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway. J Biol Chem. 2005, 280: 13616-13623. 10.1074/jbc.M411999200. Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C, Almeida K, Wang J, Doble B, Woodgett J, Wynshaw-Boris A, Hsieh JC, He X: Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development. 2008, 135: 367-375. Metcalfe C, Bienz M: Inhibition of GSK3 by Wnt signalling – two contrasting models. J Cell Sci. 2011, 124: 3537-3544. 10.1242/jcs.091991. Brembeck FH, Rosario M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev. 2006, 16: 51-59. 10.1016/j.gde.2005.12.007. Heuberger J, Birchmeier W: Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010, 2: a002915-10.1101/cshperspect.a002915. Henderson BR, Fagotto F: The ins and outs of APC and β-catenin nuclear transport. EMBO Rep. 2002, 3: 834-839. 10.1093/embo-reports/kvf181. Städeli R, Hoffmans R, Basler K: Transcriptional control of nuclear Arm/β-catenin. Curr Biol. 2006, 16: R378-R385. 10.1016/j.cub.2006.04.019. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R: The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO J. 2000, 19: 1839-1850. 10.1093/emboj/19.8.1839. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Züllig S, Basler K: Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin – TCF complex. Cell. 2002, 109: 47-60. 10.1016/S0092-8674(02)00679-7. Lochhead PA, Kinstrie R, Sibbet G, Rawjee T, Morrice N, Cleghon V: A chaperone-dependent GSK3β transitional intermediate mediates activation-loop autophosphorylation. Mol Cell. 2006, 24: 627-633. 10.1016/j.molcel.2006.10.009. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK, Tassa C, Berry EM, Soda T, Singh KK, Biechele T, Petryshen TL, Moon RT, Haggarty SJ, Tsai LH: Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling. Cell. 2009, 136: 1017-1031. 10.1016/j.cell.2008.12.044. Lustig B, Behrens J: The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol. 2003, 129: 199-221. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M, Deuel TF: Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ. Proc Nat Acad Sci U S A. 2000, 97: 2603-2608. 10.1073/pnas.020487997. Galceran J, Miyashita-Lin EM, Devaney E, Rubinstein JL, Grosschedl R: Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development. 2000, 127: 469-482. Lee SM, Tole S, Grove E, McMahon AP: A local Wnt-3a signal is required for development of the mammalian hippocampus. Development. 2000, 127: 457-467. Zhou CJ, Zhao C, Pleasure SJ: Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. J Neurosci. 2004, 24: 121-126. 10.1523/JNEUROSCI.4071-03.2004. Yu X, Malenka RC: β-catenin is critical for dendritic morphogenesis. Nat Neurosci. 2003, 6: 1169-1177. 10.1038/nn1132. Lie DC, Colamarino SA, Song HJ, Desire L, Mira H, Consiglio A, Lein ES, Jessberger S, Lansford H, Dearie AR, Gage FH: Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005, 437: 1370-1375. 10.1038/nature04108. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC: Wnt signaling through dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci. 2005, 8: 34-42. 10.1038/nn1374. Krylova O, Herreros J, Cleverley KE, Ehler E, Henriquez JP, Hughes SM, Salinas PC: WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons. Neuron. 2002, 35: 1043-1056. 10.1016/S0896-6273(02)00860-7. Packard M, Koo ES, Gorczyca M, Sharpe J, Cumberledge S, Budnik V: The drosophila Wnt, Wingless, provides an essential signal for pre- and postsynaptic differentiation. Cell. 2002, 111: 319-330. 10.1016/S0092-8674(02)01047-4. Chen J, Park CS, Tang SJ: Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem. 2006, 281: 11910-11916. 10.1074/jbc.M511920200. De Ferrari GV, Moon RT: The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene. 2006, 25: 7545-7553. 10.1038/sj.onc.1210064. Okerlund ND, Cheyette BN: Synaptic Wnt signaling – a contributor to major psychiatric disorders. J Neurodev Disord. 2011, 3: 162-174. 10.1007/s11689-011-9083-6. Maestrini E, Pagnamenta AT, Lamb JA, Bacchelli E, Sykes NH, Sousa I, Toma C, Barnby G, Butler H, Winchester L, Scerri TS, Minopoli F, Reichert J, Cai G, Buxbaum JD, Korvatska O, Schellenberg GD, Dawson G, de Bildt A, Minderaa RB, Mulder EJ, Morris AP, Bailey AJ, Monaco AP, IMGSAC: High density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry. 2010, 15: 954-968. 10.1038/mp.2009.34. Yang MS, Gill M: A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int J Dev Neurosci. 2007, 25: 69-85. 10.1016/j.ijdevneu.2006.12.002. Folstein SE, Mankoski RE: Chromosome 7q: where autism meets language disorder?. Am J Hum Genet. 2000, 67: 278-281. 10.1086/303034. Wassink TH, Piven J, Vieland VJ, Huan J, Swiderski RE, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC: Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet. 2001, 105: 406-413. 10.1002/ajmg.1401. McCoy PA, Shao Y, Wolpert CM, Donnely SL, Ashley-Koch A, Abel HL, Ravan SA, Abramson RK, Wright HH, DeLong GR, Cuccaro ML, Gilbert JR, Pericak-Vance MA: No association between the WNT2 gene and autistic disorder. Am J Med Genet. 2002, 114: 106-109. 10.1002/ajmg.10182. Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N, Myers RM: Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet. 2004, 126B: 51-57. 10.1002/ajmg.b.20122. Marui T, Funatogawa I, Kishi S, Yamamoto K, Matsumoto H, Hashimoto O, Jinde S, Nishida H, Sugiyama T, Kasia K, Watanabe K, Kano Y, Kato N: Association between autism and variants in the wingless-type MMTV integration site family member 2 (WNT2) gene. Int J Neuropsychopharmacol. 2010, 13: 443-449. 10.1017/S1461145709990903. Sousa KM, Villaescusa JC, Cajanek L, Ondr JK, Castelo-Branco G, Hofstra W, Bryja V, Palmberg C, Bergman T, Wainwright B, Lang RA, Arenas E: Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem. 2010, 285: 7246-7253. 10.1074/jbc.M109.079822. Wang HX, Tekpetey FR, Kidder GM: Identification of Wnt/β-catenin signaling pathway components in human cumulus cells. Mol Hum Reprod. 2009, 15: 11-17. 10.1093/molehr/gan070. Karasawa T, Yokokura H, Kitajewski J, Lombroso PJ: Frizzled-9 is activated byWnt-2 and functions in Wnt/ β-catenin signaling. J Biol Chem. 2002, 277: 37479-37486. 10.1074/jbc.M205658200. Merla G, Brunetti-Pierri N, Micale L, Fusco C: Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum Genet. 2010, 128: 3-26. 10.1007/s00439-010-0827-2. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, Chu SH, Moreau MP, Gupta AR, Thomson SA, Mason CE, Bilguvar K, Celestino-Soper PB, Choi M, Crawford EL, Davis L, Wright NR, Dhodapkar RM, DiCola M, DiLullo NM, Fernandez TV, Fielding-Singh V, Fishman DO, Frahm S, Garagaloyan R, Goh GS, Kammela S, Klei L, Lowe JK, Lund SC: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011, 70: 863-885. 10.1016/j.neuron.2011.05.002. Van der Aa N, Rooms L, Vandeweyer G, van de Ende J, Reyniers E, Fichera M, Romano C, Della Chiaie B, Mortier G, Menten B, Destrée A, Maystadt I, Männik K, Kurg A, Reimand T, McMullan D, Oley C, Brueton L, Bongers EM, van Bon BW, Pfund R, Jacquemont S, Ferrarini A, Martinet D, Schrander-Stumpel C, Stegmann AP, Frints SG, de Vries BB, Ceulemans B, Kooy RF: Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet. 2009, 52: 94-100. 10.1016/j.ejmg.2009.02.006. Berg JS, Brunetti-Pierri N, Peters SU, Kang SH, Fong CT, Salamone J, Freedenberg D, Hannig VL, Prock LA, Miller DT, Raffalli P, Harris DJ, Erickson RP, Cunniff C, Clark GD, Blazo MA, Peiffer DA, Gunderson KL, Sahoo T, Patel A, Lupski JR, Beaudet AL, Cheung SW: Speech delay and autism spectrum behaviors are frequently associated with duplications of the 7q11.23 Williams-Beuren syndrome region. Genet Med. 2007, 9: 427-441. 10.1097/GIM.0b013e3180986192. Morris CA: The behavioral phenotype of Williams syndrome: a recognizable patter of neurodevelopment. Am J Med Genet. 2010, 154C: 427-431. 10.1002/ajmg.c.30286. Zhao C, Aviles C, Abel RA, Almli CR, McQuillen P, Pleasure SJ: Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval. Development. 2005, 132: 2917-2927. 10.1242/dev.01871. Rawal N, Castelo-Branco G, Sousa KM, Kele J, Kobayashi H, Arenas E: Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. Exp Cell Res. 2006, 312: 1626-1636. 10.1016/j.yexcr.2006.01.032. Adachi S, Jigami T, Yasui T, Nakano T, Ohwada S, Omori Y, Sugano S, Ohkwara B, Shibuya H, Nakamura T, Akiyama T: Role of BCL9-related β-catenin binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling. Cancer Res. 2004, 64: 8496-8501. 10.1158/0008-5472.CAN-04-2254. Mefford H, Sharp A, Baker C, Itsara A, Jiang Z, Buysse K, Huang S, Maloney V, Crolla J, Barella D, Collins A, Mercer C, Norga K, de Ravel T, Devriendt K, Bongers EM, de Leeuw N, Reardon W, Gimelli S, Bena F, Hennekam RC, Male A, Gaunt L, Clayton-Smith J, Simonic I, Park SM, Mehta SG, Nik-Zainal S, Woods CG, Firth HV: Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med. 2008, 359: 1685-1699. 10.1056/NEJMoa0805384. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, Lalani SR, Graham B, Lee B, Shinawi M, Shen J, Kang SH, Pursley A, Lotze T, Kennedy G, Lansky-Shafer S, Weaver C, Roeder ER, Grebe TA, Arnold GL, Hutchison T, Reimschisel T, Amato S, Geragthy MT, Innis JW, Obersztyn E, Nowakowska B, Rosengren SS, Bader PI, Grange DK: Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008, 40: 1466-1471. 10.1038/ng.279. Ma DQ, Cuccaro ML, Jaworski JM, Haynes CS, Stephan DA, Parod J, Abramson RK, Wright HH, Gilbert JR, Haines JL, Pericak-Vance MA: Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14. Mol Psychiatry. 2007, 12: 376-384. 10.1038/sj.mp.4001927. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT: PAR-1 is a dishevelled-associated kinase and positive regulator of Wnt signalling. Nat Cell Biol. 2001, 3: 628-636. 10.1038/35083016. Bernatik O, Ganji RS, Dijksterhuis JP, Konik P, Cervenka I, Polonio T, Krejci P, Schulte G, Bryja V: Sequential activation and inactivation of dishevelled in the Wnt/β-catenin pathway by casein kinases. J Biol Chem. 2011, 286: 10396-10410. 10.1074/jbc.M110.169870. Maussion G, Carayol J, Lepagnol-Bestel AM, Tores F, Loe-Mie Y, Milbreta U, Rousseau F, Fontaine K, Renaud J, Moalic JM, Philippi A, Chedotal A, Gorwood P, Ramoz N, Hager J, Simonneau M: Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism. Hum Mol Genet. 2008, 17: 2541-2551. 10.1093/hmg/ddn154. Okamoto N, Hatsukawa Y, Shimojima K, Yamamoto T: Submicroscopic deletion in 7q31 ecompassing CADPS2 and TSPAN12 in a child with autism spectrum disorder. Am J Med Genet. 2011, 155A: 1568-1573. David MD, Yeramian A, Dunach M, Llovera M, Canti C, de Herreros AG, Comella JX, Herreros J: Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential β-catenin phosphorylation. J Cell Sci. 2008, 121: 2718-2730. 10.1242/jcs.029660. Papkoff J, Aikawa M: WNT-1 and HGF regulate GSK3β activity and β-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun. 1998, 247: 851-858. 10.1006/bbrc.1998.8888. Hiscox S, Jiang WG: Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun. 1999, 261: 406-411. 10.1006/bbrc.1999.1002. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P: Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci. 2003, 23: 622-631. Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P: Dynamic gene and protein expression patterns of the autism-associated Met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol. 2009, 513: 511-531. 10.1002/cne.21969. Finsterwald C, Martin JL: Cellular mechanisms underlying the regulation of dendritic development by hepatocyte growth factor. Eur J Neurosci. 2011, 34: 1053-1061. 10.1111/j.1460-9568.2011.07839.x. Mukamel Z, Konopka G, Wezler E, Osborn G, Dong H, Bergman MY, Levitt P, Geschwind DH: Regulation of MET by FOXP2, genes implcated in higher cognitive dysfunction and autism risk. J Neurosci. 2011, 31: 11437-11442. 10.1523/JNEUROSCI.0181-11.2011. Campbell DB, D’Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, Persico AM: Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol. 2007, 62: 243-250. 10.1002/ana.21180. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, Summers A, Gibbons CA, Teebi A, Chitayat D, Weksberg R, Thompson A, Vardy C, Crosbie V, Luscombe S, Baatjes R: Structural variations of chromosomes in autism disorder. Am J Hum Genet. 2008, 82: 477-488. 10.1016/j.ajhg.2007.12.009. Yagi T, Takeichi M: Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 2000, 14: 1169-1180. Arikkath J, Reichardt LF: Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci. 2008, 31: 487-494. 10.1016/j.tins.2008.07.001. Pagnamenta AT, Khan H, Walker S, Gerrelli D, Wing K, Bonaglia MC, Giorda R, Berney T, Mani E, Molteni M, Pinto D, Le Couteur A, Hallmayer J, Sutcliffe JS, Szatmari P, Paterson AD, Scherer SW, Vieland VJ, Monaco AP: Rare familial 16q21 microdeletions under a linkage peak indicate cadherin 8 (CDH8) in susceptibility to autism and learning disability. J Med Genet. 2011, 48: 48-54. 10.1136/jmg.2010.079426. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D, Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E, Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J, Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI, Dong H, Hutman T, Sigman M, Ozonoff S, Klin A: Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009, 459: 528-533. 10.1038/nature07999. Willemsen MH, Fernandez BA, Bacino CA, Gerkes E, de Brouwer APM, Pfundt R, Sikkema-Raddatz B, Scherer SW, Marshall CR, Potocki L, van Bokhoven H, Kleefstra T: Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome. Eur J Hum Genet. 2010, 18: 429-435. 10.1038/ejhg.2009.192. Mak BC, Takemaru KI, Kenerson HL, Moon RT, Yeung RS: The tuberin-hamartin complex negatively regulates β-catenin signaling activity. J Biol Chem. 2003, 278: 5947-5951. 10.1074/jbc.C200473200. Orlova KA, Crino PB: The tuberous sclerosis complex. Ann N Y Acad Sci. 2010, 1184: 87-105. 10.1111/j.1749-6632.2009.05117.x. Wiznitzer M: Autism and tuberous sclerosis. J Child Neurol. 2004, 19: 675-679. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ: Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990, 336: 13-16. 10.1016/0140-6736(90)91520-K. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA: Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry. 2008, 13: 173-186. 10.1038/sj.mp.4002079. Brandon NJ, Sawa A: Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011, 12: 707-722. 10.1038/nrn3120. Porteous DJ, Millar JK, Brandon NJ, Sawa A: DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol Med. 2011, 17: 699-706. 10.1016/j.molmed.2011.09.002. Kilpinen H, Ylisaukko-oja T, Hennah W, Palo OM, Varilo T, Vanhala R, Nieminen-von Wendt T, von Wendt L, Paunio T, Peltonen L: Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry. 2008, 13: 187-196. 10.1038/sj.mp.4002031. Hennah W, Thomson P, Peltonen L, Porteous D: Genes and schizophrenia: the role of DISC1 in major mental illness. Schizophr Bull. 2006, 32: 409-416. Walker RM, Hill AE, Newman AC, Hamilton G, Torrance HS, Anderson SM, Ogawa F, Derizioti P, Nicod J, Vernes SC, Fisher SE, Thomson PA, Porteous DJ, Evans KL: The DISC1 promoter: characterization and regulation by FOXP2. Hum Mol Genet. 2012, 21: 2862-2872. 10.1093/hmg/dds111. Barber JC, Ellis KH, Bowles LV, Delhanty JD, Ede RF, Male BM, Eccles DM: Adenomatous polyposis coli and a cytogenic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion. J Med Genet. 1994, 31: 312-316. 10.1136/jmg.31.4.312. Zhou XL, Giacobini M, Anderlid BM, Anckarsäter H, Omrani D, Gillberg C, Nordenskjöld M, Lindblom A: Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD). Am J Med Genet. 2007, 144B: 351-354. 10.1002/ajmg.b.30415. Pagnamenta AT, Bacchelli E, de Jonge MV, Mirza G, Scerri TS, Minopoli F, Chiocchetti A, Ludwig KU, Hoffmann P, Paracchini S, Lowy E, Harold DH, Chapman JA, Klauck SM, Poustka F, Houben RH, Staal WG, Ophoff RA, O'Donovan MC, Williams J, Nöthen MM, Schulte-Körne G, Deloukas P, Ragoussis J, Bailey AJ, Maestrini E, Monaco AP, International Molecular Genetic Study Of Autism Consortium: Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry. 2010, 68: 320-328. 10.1016/j.biopsych.2010.02.002. Upadhyay G, Goessling W, North TE, Xavier R, Zon LI, Yajnik V: Molecular association between β-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/β-catenin signaling. Oncogene. 2008, 27: 5845-5855. 10.1038/onc.2008.202. Ueda S, Fujimoto S, Hiramoto K, Negishi M, Katoh H: Dock4 regulates dendritic development in hippocampal neurons. J Neurosci Res. 2008, 86: 3052-3061. 10.1002/jnr.21763. Alvarez Retuerto AI, Cantor RM, Gleeson JG, Ustaszewska A, Schackwitz WS, Pennacchio LA, Geschwind DH: Association of common variants in the Joubert syndrome gene (AHI1) with autism. Hum Mol Genet. 2008, 17: 3887-3896. 10.1093/hmg/ddn291. Parisi MA, Doherty D, Chance PF, Glass IA: Joubert syndrome (and related disorders) (OMIM 213300). Eur J Hum Genet. 2007, 15: 511-521. 10.1038/sj.ejhg.5201648. Doering JE, Kane K, Hsiao YC, Yao C, Shi B, Slowik AD, Dhagat B, Scott DD, Ault JG, Page-McCaw PS, Ferland RJ: Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies. J Comp Neurol. 2008, 511: 238-256. 10.1002/cne.21824. Ferland RJ, Eyaid W, Collura RV, Tully LD, Hill RS, Al-Nouri D, Al-Rumayyan A, Topcu M, Gascon G, Bodell A, Shugart YY, Ruvolo M, Walsh CA: Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat Genet. 2004, 36: 1008-1013. 10.1038/ng1419. Lancaster MA, Louie CM, Silhavy JL, Sintasath L, DeCambre M, Nigam SK, Willert K, Gleeson JG: Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med. 2009, 15: 1046-1054. 10.1038/nm.2010. Tripathi PP, Sgado P, Scali M, Viaggi C, Casarosa S, Simon HH, Vaglini F, Corsini GU, Bozzi Y: Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. Neuroscience. 2009, 159: 842-849. 10.1016/j.neuroscience.2009.01.007. McGrew LL, Takemaru KI, Bates R, Moon RT: Direct regulation of Xenopus engrailed-2 promoter by the Wnt signaling pathway, and a molecular screen for Wnt-responsive genes, confirm a role for Wnt signaling during neural patterning in Xenopus. Mech Dev. 1999, 87: 21-32. 10.1016/S0925-4773(99)00136-7. Benayed R, Choi J, Matteson PG, Gharani N, Kamdar S, Brzustowicz LM, Millonig JH: Autism-associated haplotype affects the regulation of the homeobox gene, ENGRAILED 2. Biol Psychiatry. 2009, 66: 911-917. 10.1016/j.biopsych.2009.05.027. Yang P, Shu BC, Hallmayer JF, Lung FW: Intronic single nucleotide polymorphisms of Engrailed Homeobox 2 modulate the disease vulnerability of autism in a Han Chinese population. Neuropsychobiology. 2010, 62: 104-115. 10.1159/000315441. Cheh MA, Millonig JH, Roselli LM, Ming X, Jacobsen E, Kamdar S, Wagner GC: En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Res. 2006, 1116: 166-176. 10.1016/j.brainres.2006.07.086. Di Nardo AA, Nedelec S, Trembleau A, Volovitch M, Prochiantz A, Montesinos ML: Dendritic localization and activity-dependent translation of Engrailed1 transcription factor. Mol Cell Neurosci. 2007, 35: 230-236. 10.1016/j.mcn.2007.02.015. Roelfsema JH, Peters DJ: Rubinstein-Taybi syndrome: clinical and molecular overview. Exp Rev Mol Med. 2007, 9: 1-16. Schorry EK, Keddache M, Lanphear N, Rubinstein JH, Srodulski S, Fletcher D, Blough-Pfau RI, Grabowski GA: Genotype-phenotype correlations in Rubinstein-Taybi syndrome. Am J Med Genet. 2008, 146A: 2512-2519. 10.1002/ajmg.a.32424. Marangi G, Leuzzi V, Orteschi D, Grimaldi ME, Lecce R, Neri G, Zollino M: Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype. Am J Med Genet. 2008, 146A: 2313-2317. 10.1002/ajmg.a.32460. Thienpont B, Bena F, Breckpot J, Philip N, Menten B, Van Esch H, Scalais E, Salamone JM, Fong CT, Kussmann JL, Grange DK, Gorski JL, Zahir F, Yong SL, Morris MM, Gimelli S, Fryns JP, Mortier G, Friedman JM, Villard L, Bottani A, Vermeesch JR, Cheung SW, Devriendt K: Duplications of the critical Rubinstein-Taybi deletion region on chromosome 16p13.3 cause a novel recognisable syndrome. J Med Genet. 2010, 47: 155-161. 10.1136/jmg.2009.070573. Rasalam AD, Hailey H, Williams JHG, Moore SJ, Turnpenny PD, Lloyd DJ, Dean JCS: Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol. 2005, 47: 551-555. 10.1017/S0012162205001076. Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JC: A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000, 37: 489-497. 10.1136/jmg.37.7.489. Schneider T, Przewlocki R: Behavoral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005, 30: 80-89. 10.1038/sj.npp.1300518. Wang Z, Xu L, Zhu X, Cui W, Sun Y, Nisjijo H, Peng Y, Li R: Demethylation of specific Wnt/β-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure. Anat Rec. 2010, 293: 1947-1953. 10.1002/ar.21232. Levitt P: Serotonin and the autisms; a red flag or a red herring?. Arch Gen Psychiatry. 2011, 68: 1093-1094. 10.1001/archgenpsychiatry.2011.98. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V: Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry. 2011, 68: 1104-1112. 10.1001/archgenpsychiatry.2011.73. Simpson KL, Weaver KJ, de Villers-Sidani E, Lu JY, Cai Z, Pang Y, Rodriguez-Porcel F, Paul IA, Merzenich M, Lin RC: Perinatal antidepressant exposure alters cortical network function in rodents. Proc Nat Acad Sci U S A. 2011, 108: 18465-18470. 10.1073/pnas.1109353108. Okamoto H, Voleti B, Banasr M, Sarhan M, Duric V, Girgenti MJ, DiLeone RJ, Newton SS, Duman RS: Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol Psychiatry. 2010, 68: 521-527. 10.1016/j.biopsych.2010.04.023. McCaffery P, Deutsch CK: Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol. 2005, 77: 38-56. 10.1016/j.pneurobio.2005.10.005. Haegele L, Ingold B, Naumann H, Tabatabai G, Ledermann B, Brandner S: Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenic protein expression. Mol Cell Neurosci. 2003, 24: 696-708. 10.1016/S1044-7431(03)00232-X. Vlad A, Röhrs S, Klein-Hitpass L, Müller O: The first five years of the Wnt targetome. Cell Signal. 2008, 20: 795-802. 10.1016/j.cellsig.2007.10.031. Hooper C, Killick R, Fernandes C, Sugden D, Lovestone S: Transcriptomic profiles of Wnt3a and insulin in primary cultured rat cortical neurones. J Neurochem. 2011, 118: 512-520. 10.1111/j.1471-4159.2011.07349.x. Wan XZ, Li B, Li YC, Yang XL, Zhang W, Zhong L, Tang SJ: Activation of NMDA receptors upregulates a disintegrin and metalloproteinase 10 via a Wnt/MAPK signaling pathway. J Neurosci. 2012, 32: 3910-3916. 10.1523/JNEUROSCI.3916-11.2012. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E, Ben-Ze ev A: Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 2007, 67: 7703-7712. 10.1158/0008-5472.CAN-07-0991. LeBlanc JJ, Fagiolini M: Autism: a “critical period” disorder?. Neural Plast. 2011, 201 (1): 921680- Wexler EM, Geschwind DH, Palmer TD: Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 2008, 13: 285-292. 10.1038/sj.mp.4002093. Gould TD, Gray NA, Manji HK: Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adonomatous polyposis coli mutant mice. Pharmacol Res. 2003, 48: 49-53. Cohen Y, Chetrit A, Cohen Y, Sirota P, Modan B: Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol. 1998, 15: 32-36. 10.1007/BF02787342. Lee HJ, Wang NX, Shi DL, Zheng JJ: Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein dishevelled. Angew Chem Int Ed Engl. 2009, 48: 6448-6452. 10.1002/anie.200902981. Han A, Song Z, Tong C, Hu D, Bi X, Augenlicht LH, Yang W: Sulindac suppresses β-catenin expression in human cancer cells. Eur J Pharmacol. 2008, 583: 26-31. 10.1016/j.ejphar.2007.12.034. Wilkinson MB, Dias C, Magida J, Mazei-Robinson M, Lobo MK, Kennedy P, Dietz D, Covington H, Russo S, Neve R, Ghose S, Tamminga C, Nestler EJ: A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci. 2011, 31: 9084-9092. 10.1523/JNEUROSCI.0039-11.2011.